Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent ...

Gilead has plans for a rapid launch in the United States as well as a wider rollout of the drug in collaboration with global ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences’ twice-yearly injection to prevent HIV - a move the ...

Lenacapavir belongs to a new class of antiretrovirals known as capsid inhibitors. In large-scale clinical trials conducted ...